In vitro activity of twelve antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
3 Tuberculosis (TB) remains a major health problem worldwide and is one of the leading causes of 28 death by a single infectious agent, that is, Mycobacterium tuberculosis. According to the World 29 Health Organization in 2016 there were an estimated 10.4 million new TB cases and 1.6 million TB 30 deaths [1] . Furthermore, the emergence of multidrug-resistant (MDR) TB and extensively drug-31 resistant (XDR) TB has led to the need to develop new treatment options [2] . 32 Infections produced by nontuberculous mycobacteria (NTM) have dramatically increased in the last 33 years, mainly in immunocompromised patients and individuals with pre-existing pulmonary diseases. 34 Among these NTM, Mycobacterium avium is of note and is gaining increasingly more relevant 35 clinical significance. The high levels of natural drug resistance of NTM lead to poor treatment 36 outcomes requiring novel drug regimens and compounds [3] .
37
Antimicrobial peptides (AMPs) are powerful natural antibiotics produced by all life forms from 38 microorganisms to humans [4] [5] [6] . AMPs tend to be relatively short (20-60 amino acid residues), 39 amphipathic and positively charged. Four main structural AMPs classes have been defined: α-helix, 
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The objective of the present study was to investigate the activity of 12 different AMPs (bactenecin, 55 buforin I, mastoparan, indolicidin, histatin 5, histatin 8, magainin I, magainin II, cecropin PI, cecropin 
64
Of the 12 AMPs studied, histatin 5, magainin I, magainin II, cecropin PI, cecropin A and cecropin B 65 were provided by Sigma-Aldrich (St. Louis, MO, USA). On the other hand, bactenecin, buforin I, 66 mastoparan, indolicidin, histatin 8 and melittin were purchased from BionovaCientifica (S.L.,
67
Madrid, Spain) ( Table 1 ) [12] . The lyophilized AMPs were dissolved in sterile distilled water and 68 sterilized by filtration. Then, they were stored at -20°C in aliquots until use. All the AMPs were tested 69 at concentrations ranging from 128 µg ml -1 to 0.125 µg ml -1 . The AMPs were selected based on the 70 activity shown against mycobacteria and other bacterial species described in previous studies as well 71 as their availability and affordability [8] . The MIC values obtained are shown in Table 2 . When tested against M. tuberculosis, mastoparan and 102 melittin showed the best activity, with MIC values ranging from 32-64 µg ml -1 . Indolicidin showed 103 MIC values of 32 µg ml -1 against 2 of the isolates and of 64 µg ml -1 against 1 isolate. The other AMPs 104 showed higher MICs (>128 µg ml -1 ).
105
Regarding M. avium, indolicidin had the greatest activity with MIC values of 128 µg ml -1 . All the 106 remaining AMPs showed MICs >128 µg ml -1 . The activity of AMPs against mycobacteria is probably lower than in Gram-negative and other Gram-116 positive bacteria [15] . In the present study, we tested a set of 12 AMPs previously tested against other 117 bacteria but rarely studied or with unknown activity against mycobacteria. As shown in Table 2 , 118 mastoparan and melittin showed better results against M. tuberculosis than the other AMPs. In a 119 previous study these two AMPs also showed a good activity against Acinetobacter baumanii [12] . 120 However, these AMPs were less effective against the M. avium isolates. Differences in membrane 121 composition may affect the activity of the AMPs. Therefore, we hypothesized that they may present 122 a different efficacy in other mycobacterial species, suggesting that each AMP should be specifically 123 tested in each species. Moreover, the mycobacterial cell membrane has a distinct architecture with a 124 lipid-rich envelope, and taking into account the cationic and amphipathic nature of these peptides 125 AMPs targeting mycobacterial membrane lipids could be further explored.
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Several AMPs have shown to cause membrane permeabilization, which would facilitate the entry of 127 drugs into the mycobacterial cell and allow interaction with intracellular targets [18] . From this point 128 of view, AMPs could have greater activity or even synergism when combined with antibiotics. 
